Title : Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase.

Pub. Date : 2020 Mar 20

PMID : 32511320






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, using polymerase extension experiments, we have demonstrated that the active triphosphate form of Sofosbuvir (a key component of the FDA approved hepatitis C drug EPCLUSA), is incorporated by SARS-CoV-2 RdRp, and blocks further incorporation. Sofosbuvir ORF1a polyprotein;ORF1ab polyprotein Severe acute respiratory syndrome coronavirus 2